The North America Minimally Invasive Surgery Robot Market is expected to reach US$ 13,392.9 million by 2031, rising from US$ 5,084.7 million in 2024 and registering a CAGR of 15.0% during the forecast period from 2025 to 2031. Market growth is being supported by the increasing adoption of robotic-assisted surgical procedures, rising prevalence of chronic diseases, growing demand for minimally invasive interventions, advances in surgical robotics, and increasing investment in next-generation robotic platforms. The availability of advanced healthcare infrastructure and growing regulatory approvals for robotic surgical systems are further strengthening market expansion across North America.

What is driving the North America Minimally Invasive Surgery Robot Market?

The growing preference for minimally invasive procedures is a major factor driving the North America Minimally Invasive Surgery Robot Market. Robotic-assisted systems provide surgeons with enhanced visualization, improved dexterity, motion scaling, and greater precision during complex procedures. These capabilities can support surgeries performed through smaller incisions and may contribute to reduced blood loss, shorter hospital stays, and faster postoperative recovery compared with conventional open procedures.

The increasing prevalence of chronic diseases is another important growth factor. Conditions such as cancer, cardiovascular diseases, obesity, and orthopedic disorders frequently require surgical intervention. As the number of surgical procedures increases, hospitals are seeking advanced technologies that can improve surgical precision and workflow efficiency. The growing number of complex microsurgeries is also encouraging the adoption of robotic technologies capable of supporting precise manipulation of small anatomical structures.

Download Sample PDF: 

Which country leads the North America Minimally Invasive Surgery Robot Market?

The United States is expected to remain the leading country in the North America Minimally Invasive Surgery Robot Market. The country has a highly developed healthcare infrastructure, high healthcare expenditure, substantial surgical volumes, and strong adoption of advanced medical technologies. The United States also has a significant presence of leading surgical robotics companies and research institutions, supporting continuous innovation and commercialization.

The country has experienced important developments in robotic surgery. Intuitive Surgical received US FDA clearance for its next-generation da Vinci 5 multiport robotic system in March 2024. Moon Surgical also received FDA clearance for the commercial version of its Maestro surgical system in June 2024, highlighting the growing diversity of robotic platforms available to US healthcare providers.

Canada represents another important market and offers substantial growth opportunities. Increasing adoption of robotic surgery, expanding healthcare infrastructure, and growing demand for advanced surgical technologies are supporting market development. The country’s healthcare providers are also investing in robotic platforms for specialties such as spine, urology, and gynecology.

The competitive environment is becoming particularly active in 2026. Medtronic began its first US commercial cases with the Hugo robotic-assisted surgery system earlier in the year and is working to expand the platform’s applications. CMR Surgical is also expanding its presence in the US following FDA clearance for its Versius system.

Which segment leads the North America Minimally Invasive Surgery Robot Market?

The instruments and accessories segment accounted for the largest share of the minimally invasive surgery robot market in 2024. Robotic procedures require specialized instruments such as forceps, needle drivers, energy instruments, irrigators, and other accessories. Unlike robotic systems, many instruments and accessories are consumable or require replacement, creating recurring revenue opportunities for manufacturers.

By application, minimally invasive surgical robots are used across general surgery, gynecological surgery, urological surgery, neurosurgery, orthopedic surgery, and other specialties. General surgery represents an important growth area as robotic systems become increasingly capable of supporting complex laparoscopic procedures. Urological and gynecological procedures also remain significant applications because robotic platforms can provide surgeons with enhanced visualization and precision in anatomically complex procedures.

By end use, hospitals represented the largest segment in 2024. Hospitals are investing in robotic surgery programs to expand their advanced surgical capabilities, attract specialized surgeons, improve operating room efficiency, and provide patients with access to minimally invasive treatment options. Ambulatory surgery centers are also emerging as an important opportunity as robotic platforms become more compact, flexible, and suitable for outpatient procedures.

Which companies are prominent in the North America Minimally Invasive Surgery Robot Market?

The North America Minimally Invasive Surgery Robot Market includes established medical technology companies and emerging surgical robotics developers. Prominent companies include Medtronic Plc, Stryker Corp, Johnson & Johnson, Zimmer Biomet Holdings Inc, Smith & Nephew Plc, Intuitive Surgical Inc, Asensus Surgical Inc, CMR Surgical Ltd, Moon Surgical, and CUREXO, INC.

Competition is influenced by technological innovation, clinical capabilities, regulatory approvals, system cost, surgeon training, instrument portfolios, service networks, and the ability to integrate robotic systems into existing hospital workflows. Companies are increasingly developing platforms designed to provide greater flexibility while expanding robotic surgery into new specialties and sites of care.

The competitive environment has intensified in 2026 as Medtronic, CMR Surgical, Stryker, and other companies introduce or expand robotic platforms. Medtronic submitted US 510(k) filings in June 2026 seeking to expand Hugo into general and gynecologic surgery, while also pursuing additional instruments for the platform. CMR Surgical reported in March 2026 that more than 45,000 patients worldwide had been treated using its Versius Surgical Robotic System as it prepared for broader US expansion.

The companies listed above represent prominent participants in the industry and are not presented as a revenue-ranked market-share table. Competitive positioning can vary across products, technologies, applications, and geographic markets.

What is changing in 2026?

In 2026, the North America Minimally Invasive Surgery Robot Market is experiencing a shift toward greater platform competition, AI-enabled surgical assistance, flexible robotic systems, and expansion into ambulatory surgery centers. New market entrants are challenging established robotic surgery platforms, giving hospitals more choices when developing or expanding robotic surgery programs.

AI is becoming an increasingly important area of development. Intuitive Surgical outlined an AI framework in July 2026 focused on reducing variability, improving outcomes, shortening learning curves, and expanding surgeon capabilities. The company said its development approach draws on data from more than 20 million da Vinci procedures.

Modular and portable robotic systems are also gaining attention. Smaller platforms can potentially be moved between operating rooms or departments, helping hospitals maximize utilization. This approach is particularly relevant to ambulatory surgery centers, where space, capital expenditure, and operating efficiency are important considerations.

What are the major investment opportunities?

Major investment opportunities in the North America Minimally Invasive Surgery Robot Market are emerging across robotic surgical systems, advanced instruments and accessories, AI-assisted surgery, surgical navigation, imaging integration, remote collaboration, and robotic platforms designed for ambulatory surgery centers.

The expansion of robotic surgery into additional specialties represents a significant opportunity. Companies developing systems for general surgery, gynecology, urology, orthopedics, neurosurgery, and other procedures can benefit from the broader adoption of robotic-assisted techniques.

There is also strong potential in recurring revenue models based on instruments, accessories, maintenance, software, and service contracts. As the installed base of surgical robots grows, demand for compatible instruments and supporting services is expected to increase.

AI and data-driven surgical technologies offer another long-term investment opportunity. Advanced systems that analyze surgical data, support planning, improve workflow, and assist surgeons could become increasingly important as robotic surgery evolves.

About Us

The Insight Partners is a one-stop provider of actionable industry research and intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Healthcare IT, Manufacturing and Construction, Medical Devices, Technology, Media and Telecommunications, Food and Beverages, Consumer Goods, and Chemicals and Materials.

Contact Us

Contact Person: Ankit Mathur

Phone: +1-646-491-9876

E-mail : [email protected]